Joe Elassal, MD, MBA
Ankyra Therapeutics
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ann Silk, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Barbara Murphy, MD
Vanderbilt-Ingram Cancer Center
Shared therapeutic areas:
Jinming Yu, PhD
Shandong Cancer Hospital and Institute
Shared therapeutic areas:
Howard Berger, MD
Unity Health Toronto
Shared therapeutic areas:
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jianmin Fang, Ph.D
RemeGen Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
All 1 trials loaded